1. Home
  2. Browse Decisions
  3. ENDO PHARMACEUTICALS INC. v. ACTAVIS INC.
 

ENDO PHARMACEUTICALS INC. v. ACTAVIS INC.

Civil Action No. 14-1381-RGA.

ENDO PHARMACEUTICALS INC. and MALLINCKRODT LLC, Plaintiffs, v. ACTAVIS INC., ACTAVIS SOUTH ATLANTIC LLC, ACTAVIS PHARMA, INC., ACTAVIS ELIZABETH LLC, ACTAVIS HOLDCO U.S., INC., and TEVA PHARMACEUTICALS USA, INC., Defendants.

United States District Court, D. Delaware.

August 30, 2017.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

Endo Pharmaceuticals Inc., Plaintiff, represented by Jack B. Blumenfeld , Morris, Nichols, Arsht & Tunnell LLP.

Endo Pharmaceuticals Inc., Plaintiff, represented by Blake B. Greene , pro hac vice, Joseph J. Gribbin , pro hac vice, Sharon K. Gagliardi , pro hac vice & Stephen J. Kraftschik , Morris, Nichols, Arsht & Tunnell LLP.

Mallinckrodt LLC, Plaintiff, represented by Jack B. Blumenfeld , Morris, Nichols, Arsht & Tunnell LLP & Stephen J. Kraftschik , Morris, Nichols, Arsht & Tunnell LLP.

Actavis LLC, Defendant, represented by Adam Wyatt Poff , Young, Conaway, Stargatt & Taylor LLP, Eric H. Yecies , pro hac vice, Howard S. Suh , pro hac vice & John C. O'Quinn , pro hac vice.

Actavis LLC, f/k/a Actavis Inc., Defendant, represented by Nicholas P. Chiara , pro hac vice.

Actavis LLC, Defendant, represented by Robert M. Vrana , Young, Conaway, Stargatt & Taylor LLP & William H. Burgess , pro hac vice.

Actavis South Atlantic LLC, Defendant, represented by Adam Wyatt Poff , Young, Conaway, Stargatt & Taylor LLP & Robert M. Vrana , Young, Conaway, Stargatt & Taylor LLP.

Teva Pharmaceuticals USA, Inc., Defendant, represented by Adam Wyatt Poff , Young, Conaway, Stargatt & Taylor LLP, Mark C. McLennan , pro hac vice & Robert M. Vrana , Young, Conaway, Stargatt & Taylor LLP.

TRIAL OPINION

Plaintiffs brought this patent infringement action against two Actavis defendants on November 7, 2014, alleging that they had infringed U.S. Patent No. 8,871,779 ("the '779 patent") by filing Abbreviated New Drug Application ("ANDA") No. 20-3930 seeking to enter the market with a generic...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases